This inventor holds 1 USPTO granted patent. Top assignee: Macau University of Science and Technology. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations by Fen Yang in Autoimmune Disease Treatment
Introduction
Fen Yang is an innovative inventor based in Taipa, MO. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His work focuses on utilizing limonoids to provide new therapeutic options for patients suffering from these conditions.
Latest Patents
Fen Yang holds a patent for a method of treating autoimmune diseases, specifically targeting conditions such as systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis. The patent describes a method that involves administering an effective amount of a limonoid to the subject. This invention also includes methods for inhibiting the differentiation of various T helper cells, which play a crucial role in the immune response. The potential of this invention lies in its ability to attenuate inflammatory lymphocyte function, offering promising treatment options for those affected by autoimmune diseases. He has 1 patent to his name.
Career Highlights
Fen Yang is affiliated with the Macau University of Science and Technology, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on the treatment of autoimmune diseases.
Collaborations
Fen Yang collaborates with notable colleagues, including Liang Liu and Ting Li, who contribute to his research efforts and innovations in the field.
Conclusion
Fen Yang's innovative approach to treating autoimmune diseases through the use of limonoids represents a significant advancement in medical research. His contributions are paving the way for new therapeutic options that could improve the quality of life for many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile